Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.79, $0.27 better than the analyst estimate of $0.52. Revenue for the quarter came in at $163 million versus the consensus estimate of $144.1 million.

GUIDANCE:

Repligen sees FY2021 revenue of $625-645 million, versus the consensus of $585.9 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.